Products Resources产品中心
CONTACT US
-
400 179 0116
24-hour service hotline
Current position：Home > Products > Cell Customization > Tumor Cell Lines > human Tumor cells > CERV-196-
Products Description
The CERV-196 cell line was established from a poorly differentiated squamous cell carcinoma of the cervix; HPV-16 positive. In vitro established from the xenotransplant cervix carcinoma MRI-H-196 by Cell Lines Service. Primary xenotransplant was adopted to in vivo transplantation by Dr. Bodgen, Mason Research Institute.
